You are here

Novo Nordisk

Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial

BioPharma Dive

Thu, 02/4/16 - 09:27 am

Novo Nordisk outstrips rivals with 8% growth, but lower profits target spooks investors

Fierce Pharma

Wed, 02/3/16 - 05:44 pm

Marketing challenges remain in crowded metabolic market

Medical Marketing and Media

Tue, 01/26/16 - 09:16 pm

Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share

Fierce Pharma

Tue, 01/26/16 - 12:36 pm

Novo Nordisk eyes the future, expands presence in Iran as sanctions lift

BioPharma Dive

Fri, 01/22/16 - 09:30 pm

How Is Novo Nordisk’s Position in the Diabetes Segment?

Yahoo/Market Realist

Mon, 01/18/16 - 08:22 pm

What to Expect from Novo Nordisk’s 4Q15 Earnings

Yahoo/Market Realist

Mon, 01/18/16 - 08:22 pm

China’s diabetes boom promises $23 billion pot for drug makers

Marketwatch

Fri, 01/15/16 - 02:30 pm

Zhejiang Hisun Pharma

Novo Nordisk reinforces its commitment to fight 'urban diabetes' for the New Year

Fierce Pharma Marketing

Tue, 01/5/16 - 11:17 am

Novo Nordisk: Make-And-Take Strategy For The Obesity Drug Market

Seeking Alpha

Wed, 12/30/15 - 06:55 pm

Sanofi takes an FDA shortcut with its diabetes combo, racing with Novo

Fierce Biotech

Wed, 12/23/15 - 09:34 pm

Novo Nordisk eyes stepped-up diabetes care in 'beyond the pill' deal with IBM Watson

Fierce Pharma Marketing

Mon, 12/14/15 - 10:34 pm

With Paris spotlight on climate change, here's how Big Pharma stacks up

Fierce Pharma

Wed, 12/9/15 - 11:46 am

Bristol-Myers Squibb

Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster

Seeking Alpha

Fri, 11/27/15 - 11:59 am

Novo Nordisk's PIONEER Trial Will Establish A New Frontier In Oral Anti-Diabetics

Seeking Alpha

Sat, 11/21/15 - 12:28 pm

Drug makers beat diabetes lawsuits with an unusual ruling

Pharmalot

Fri, 11/13/15 - 08:49 pm

Victoza Brings About No Effects To Help Control Heart Failure

Bidness, ETC

Tue, 11/10/15 - 03:54 pm

Boehringer Ingelheim

These Drugs Could Deliver $5 Billion (or More) in Annual Sales

Motley Fool

Sun, 11/1/15 - 11:12 am

Intra-Cellular Therapies

Sanofi, Novo Slump as Diabetes Moves on From Insulin Tradition

Bloomberg

Thu, 10/29/15 - 09:36 am

Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases

Forbes

Wed, 10/14/15 - 02:15 pm

Bristol-Myers Squibb

Teva Pharmaceutical

Pages